Ongaro et al. [47] assessed whether the polymorphisms 676T>G in the TNFR2 gene could affect the clinical response in 105 RA patients who received anti-TNFα therapy with ADA for one year according to the ACR criteria [73]. The gene discussed is TNFRSF1B; the disease is rheumatoid arthritis.